USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Subscribe To Our Newsletter & Stay Updated